Legend Biotech (LEGN) Return on Invested Capital: 2021-2024
Historic Return on Invested Capital for Legend Biotech (LEGN) over the last 1 years, with Sep 2024 value amounting to -0.26%.
- Legend Biotech's Return on Invested Capital fell 24.00% to -0.26% in Q3 2024 from the same period last year, while for Sep 2024 it was -0.26%, marking a year-over-year decrease of 24.00%. This contributed to the annual value of -0.18% for FY2023, which is N/A change from last year.
- Legend Biotech's Return on Invested Capital amounted to -0.26% in Q3 2024, which was down 1.53% from -0.26% recorded in Q2 2024.
- Legend Biotech's 5-year Return on Invested Capital high stood at -0.03% for Q3 2023, and its period low was -0.86% during Q1 2021.
- Moreover, its 3-year median value for Return on Invested Capital was -0.31% (2024), whereas its average is -0.28%.
- In the last 5 years, Legend Biotech's Return on Invested Capital skyrocketed by 47bps in 2022 and then fell by 24bps in 2024.
- Legend Biotech's Return on Invested Capital (Quarterly) stood at -0.49% in 2021, then skyrocketed by 47bps to -0.38% in 2022, then reached -0.38% in 2023, then dropped by 24bps to -0.26% in 2024.
- Its last three reported values are -0.26% in Q3 2024, -0.26% for Q2 2024, and -0.36% during Q1 2024.